Radiation doses for CT scans may decrease when information is shared between institutions.
Monitoring and comparing CT radiation doses across institutions results in lower radiation doses for chest and abdominal CT and more consistent doses for head CT, according to a study published in JAMA Internal Medicine. Researchers from California performed a before/after interventional study to assess the impact of institutional-level audits and collaborative efforts to share best practices on CT radiation doses across five University of California (UC) medical centers. The researchers prospectively collected radiation dose metrics on all diagnostic CT examinations performed between Oct. 1, 2013, and Dec. 31, 2014, at the five medical centers. Baseline was data from 29,594 CT scans performed over a three-month period. From this, the researchers created audit reports detailing the distribution of radiation dose metrics for chest, abdomen, and head CT scans. In April, the reports were shared with the medical centers and radiology professionals from the centers were invited to a 1.5-day in-person meeting to review reports and share best practices. Data were, then, obtained from another 32,839 CT scans performed 12-to-24 weeks after the audit and meeting. To determine the impact of the audits and information-sharing, the researchers calculated changes in mean effective dose 12 weeks before and after the audits and meeting, excluding a 12-week implementation period when medical centers could make changes. They compared proportions of examinations exceeding previously published benchmarks at baseline and following the audit and meeting, and calculated changes in proportion of examinations exceeding benchmarks. The results of their study showed a decrease in mean effective dose for both chest and abdominal CTs and a slight increase for head scans. Mean effective dose: Before Audit &. After Audit &. Change in Meeting Meeting Mean DoseChest CT 13.2 mSv 10.7 mSv 18.9% reductionAbdominal CT 20.0 mSv 15.0 mSv 25.0% reductionHead 2.4 mSv. 2.5 mSv 4.0% increase Reductions at individual medical centers ranged from 3.8 percent to 23.5 percent for CT scans and from 10.8 percent to 34.7 percent for abdominal CT scans. The number of CT scans that had an effective dose measurement that exceeded benchmarks was reduced considerably by 48 percent and 54 percent for chest and abdomen, respectively. Head CT doses varied less after the audit and meeting, although some institutions increased and some decreased mean head CT doses and the proportion above benchmarks. The researchers concluded that reviewing institutional doses and sharing dose-optimization best practices resulted in lower radiation doses for chest and abdominal CT and more consistent doses for head CT.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.